Differences and instructions for dosages of Vigabatrin (vigabatrin) in children and adults

Vigabatrin (Vigabatrin) is an anti-epileptic drug that mainly inhibits epileptic seizures by irreversibly inhibiting GABA transaminase (GABA-T) and increasing the concentration of GABA in the central nervous system. This medicine is commonly used to treat infantile spasms (especially West syndrome) and complex partial epilepsy that is refractory to other medications. Due to differences in physiological metabolism, body weight, and disease types between children and adults, their dosages are also clearly distinguished.

First, in children (especially infants and young children), Vigabatrin is usually dosed by body weight. When treating infantile spasms, the recommended initial dose is 50 mg/kg/day divided into 2 divided doses. Depending on efficacy and tolerance, it can be gradually increased to a maximum of 150 mg/kg/day. Because children's nervous systems are not fully developed and their metabolic capabilities are different, dosage adjustment must be done with caution and visual function and neurobehavioral responses must be closely monitored.

In contrast, it is commonly used to treat refractory complex partial epilepsy in adult patients. The recommended starting dose is usually 1000 mg per day (taken twice in the morning and evening), and then gradually adjusted according to clinical response. The commonly used dose range is 2000 mg per day, with a maximum of 3000 mg per day. The body weight and drug metabolism ability of adult patients are more stable, so the dosage setting is relatively uniform, but long-term monitoring of visual field changes and renal function is also required.

In addition, long-term use of Vigabatrin in both children and adults carries a high risk of retinal toxicity, which can lead to irreversible visual field loss. Therefore, all patients should have regular eye examinations before starting treatment and during treatment, especially children, who are more difficult to complain of visual problems and require parents and doctors to closely monitor behavioral changes to identify side effects as early as possible.

In summary, the dose differences of Vigabatrin in pediatric and adult patients are mainly based on body weight, disease type, and metabolic characteristics. Doses are usually calculated based on body weight for children, and for adults, a fixed dose is started and titrated. Regardless of age group, visual side effects and other adverse reactions need to be strictly monitored during medication to ensure maximum efficacy and minimize risks.

Reference materials:https://www.drugs.com/